إعلان
إعلان
MYGN
Myriad Genetics Inc
6.13
USDبرعاية
-0.02
-0.24%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
6.14
+0.01
+0.16%
تقارير أرباح MYGN
النسبة الإيجابية المفاجئة
MYGN تفوق 17 من 20 آخر التقديرات.
85%
التقرير التالي
بيانات التقرير القادم
١٥ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$211.44M
/-$0.01
التغير الضمني من Q3 25 (Revenue/ EPS)
+2.79%
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
+0.40%
/-133.33%
Myriad Genetics Inc earnings per share and revenue
On ٠٣ نوفمبر ٢٠٢٥, MYGN reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 100.00% surprise. Revenue reached 205.70 مليون, compared to an expected 208.99 مليون, with a -1.58% difference. The market reacted with a -21.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 211.44 مليون USD, implying an -- of --% EPS, and increase of 2.79% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Myriad Genetics Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Myriad Genetics Inc reported EPS of $0.00, beating estimates by 100%, and revenue of $205.70M, -1.58% below expectations.
How did the market react to Myriad Genetics Inc's Q3 2025 earnings?
The stock price moved down -21.03%, changed from $8.18 before the earnings release to $6.46 the day after.
When is Myriad Genetics Inc expected to report next?
The next earning report is scheduled for ١٥ يناير ٢٠٢٦.
What are the forecasts for Myriad Genetics Inc's next earnings report?
Based on 15
analysts, Myriad Genetics Inc is expected to report EPS of -$0.01 and revenue of $211.44M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان